Ivan Trifunovich - WaferGen Bio Insider

WaferGen Bio systems Inc -- USA Stock  

USD 6.90  0.00  0.00%

Executive Chairman

Dr. Ivan D. Trifunovich, Ph.D., is Executive Chairman of the Board of WaferGen Biosystems Inc. Dr. Trifunovich has served as our Chief Executive Officer, President and director since March 2012. Dr. Trifunovich served as President, Chief Executive Officer and Chairman of the Board of Helicos BioSciences Corporationrationration1 from October 2010 to September 2012. Since August 2008, Dr. Trifunovich has served as a strategic consultant to global companies in the life sciences industry. Previously, Dr. Trifunovich served as the Senior Vice President of Third Wave Technologies, Inc., a molecular diagnostics company, from December 2001 through August 2008. Prior to joining Third Wave Technologies, Inc., Dr. Trifunovich held successive positions as Vice President of eBusiness and Vice President of Research Strategy and Operations at Pharmacia Corporationration Prior to joining Pharmacia, Dr. Trifunovich was a Director of New Product Marketing at Johnson Johnson, Inc. He began his career at BristolMyers Squibb, Inc. as a bench scientist, where he held several positions of increasing responsibility
Age: 51  Chairman Since 2015  Ph.D    
510-651-4450  http://www.wafergen.com
Trifunovich received his Ph.D. in organic. .

Ivan Trifunovich Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (90.11) % which means that it has lost $90.11 on every $100 spent on asset. This is way below average.
The company currently holds 2.94 M in liabilities with Debt to Equity (D/E) ratio of 0.8 which is about average as compared to similar companies. WaferGen Bio systems Inc has Current Ratio of 1.78 which is within standard range for the sector.

Similar Executives

Found 5 records


Thomas WroeSensata Technologies Holding PL
Michael LamachIngersoll Rand Plc
Ronald EricksonVisualant Incorporated
James CullenAgilent Technologies Inc
Joseph MarinoElectro Sensors Inc

Entity Summary

WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific. WaferGen Bio systems Inc (WGBS) is traded on Nasdaq Capital Markets in USA. It is located in CALIFORNIA, U.S.A and employs 55 people. WaferGen Bio is listed under Measuring and Control Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add WaferGen Bio systems Inc to your portfolio

Top Management

WaferGen Bio systems Leadership Team
Makoto Kaneshiro, Director, MBA
Robert Schueren, Director
Joel Kanter, Director
William McKenzie, Director
Michael Henighan, CFO
Rolland Carlson, CEO, Ph.D
Raymond Hautamaki, Director, Ph.D
Ivan Trifunovich, Chairman, Ph.D

Stock Performance

WaferGen Bio Performance Indicators